Abstract

BackgroundMost studies are inclined to report positive rather than negative or inconclusive results. It is currently unknown how clinicians appraise the results of a randomized clinical trial. For example, how does the study funding source influence the appraisal of an RCT, and do positive findings influence perceived credibility and clinical relevance? This study investigates whether psychiatrists’ appraisal of a scientific abstract is influenced by industry funding disclosures and a positive outcome.MethodsDutch psychiatrists were randomized to evaluate a scientific abstract describing a fictitious RCT for a novel antipsychotic drug. Four different abstracts were created reporting either absence or presence of industry funding disclosure as well as a positive or a negative outcome. Primary outcomes were the perceived credibility and clinical relevance of the study results (10-point Likert scale). Secondary outcomes were the assessment of methodological quality and interest in reading the full article.ResultsThree hundred ninety-five psychiatrists completed the survey (completion rate 45%). Industry funding disclosure was found not to influence perceived credibility (Mean Difference MD 0.12; 95% CI − 0.28 to 0.47, p?) nor interpretation of its clinical relevance (MD 0.14; 95% CI − 0.54 to 0.27, p?). A negative outcome was perceived as more credible than a positive outcome (MD 0.81 points; 95% Confidence Interval (CI) 0.43 to 1.18, p?), but did not affect clinical relevance scores (MD -0.14; 95% CI − 0.54 to 0.27).ConclusionsIn this study, industry funding disclosure was not associated with the perceived credibility nor judgement of clinical relevance of a fictional RCT by psychiatrists. Positive study outcomes were found to be less credible compared to negative outcomes, but industry funding had no significant effects. Psychiatrists may underestimate the influence of funding sources on research results. The fact that physicians indicated negative outcomes to be more credible may point to more awareness of existing publication bias in the scientific literature.

Highlights

  • Most studies are inclined to report positive rather than negative or inconclusive results

  • Four different abstracts were created based on reported study outcome (positive vs negative) and industry funding disclosure

  • Participant characteristics A total of 880 psychiatrists opened the invitation by email, to which 580 psychiatrists responded (66%), and 395 (45%) completed the full survey

Read more

Summary

Introduction

Most studies are inclined to report positive rather than negative or inconclusive results. A limited number of studies have addressed factors that influence physicians in their interpretation of the scientific literature This topic is important since physicians often fail to recognize the impact of conflicts of interest [14], even though a critical attitude by medical doctors towards industry funding has been found to affect the perceived relevance of a study [15]. A controversy has emerged from reanalysis of data from sponsored study 329 that showed serious side effects of antidepressants which were not reported in the initial study [19] It is unknown whether these and other factors such as study outcomes and industry funding influence the scientific evaluation of an RCT. We aimed to assess how study outcome and industry funding disclosure influence psychiatrists’ perception of credibility and clinical relevance of results of a hypothetical RCT

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call